Gardner Lewis Asset Management »

Apellis Pharmaceuticals shares owned by Gardner Lewis Asset Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Gardner Lewis Asset Management from 13F filings

Historical chart of Gardner Lewis Asset Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Gardner Lewis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Gardner Lewis Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.6M 165k 40.23

More positions owned by Gardner Lewis Asset Management

NVIDIA Corporation (NVDA)
Amicus Therapeutics (FOLD)
Sealed Air
Air Lease Corp
Tri Pointe Homes (TPH)
Ubs Group (UBS)
Arcellx (ACLX)
Boeing Company (BA)
Blue Foundry Bancorp
Apple (AAPL)
Citigroup (C)
MasterCard Incorporated (MA)
DigitalBridge Group (DBRG)
Alphabet Inc Class C cs (GOOG)
Amazon (AMZN)

View all positions for Gardner Lewis Asset Management

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals